First Eagle Investment Management, LLCFirst Eagle Investment Management, LLC

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings388 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ORACLE CORP

18.7M$2.2B5.7%$40.60+181.03%
19 qtrssince 2018-Q4
Decreased
0

META PLATFORMS INC-CLASS A

5.7M$1.6B4.2%$174.10+60.58%
19 qtrssince 2018-Q4
Decreased
0

EXXON MOBIL CORP

13.3M$1.4B3.7%$43.46+123.60%
19 qtrssince 2018-Q4
Decreased
0

HCA HOLDINGS INC

4.6M$1.4B3.5%$149.98+96.39%
19 qtrssince 2018-Q4
Decreased
0

COMCAST CORP-CLASS A

32.5M$1.3B3.4%$26.89+31.83%
19 qtrssince 2018-Q4
Decreased
0

SCHLUMBERGER LTD

27.3M$1.3B3.4%$28.83+56.63%
19 qtrssince 2018-Q4
Decreased
0

IMPERIAL OIL LTD

24M$1.2B3.1%$20.37+134.32%
19 qtrssince 2018-Q4
Increased
59
FMXFMX
Unit

FOMENTO ECONOMICO MEXICANO SAB /1 ADR REPRS 10 UT CONS 10 SERB &20 SER D-B SHS &20 SER D-L/

11M$1.2B3.1%$54.52+81.38%
14 qtrssince 2020-Q1
Decreased
0

WILLIS TOWERS WATSON PLC

5M$1.2B3.0%$185.68+21.41%
19 qtrssince 2018-Q4
Increased
55
ABEVABEV
ADR

AMBEV SA-ADR

311.6M$991M2.5%$2.04+36.09%
14 qtrssince 2020-Q1
Increased
55
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

9.1M$914.2M2.3%$33.19+192.09%
19 qtrssince 2018-Q4
Increased
54

C.H. ROBINSON WORLDWIDE INC

9.6M$905.6M2.3%$68.42+29.41%
19 qtrssince 2018-Q4
Decreased
0

PHILIP MORRIS INTERNATIONAL

9.1M$888M2.3%$48.27+81.08%
19 qtrssince 2018-Q4
Decreased
0

WHEATON PRECIOUS METALS CORP

20.4M$879.7M2.2%$21.51+93.51%
19 qtrssince 2018-Q4
Increased
54

COLGATE-PALMOLIVE CO

11.1M$854.6M2.2%$50.33+41.78%
19 qtrssince 2018-Q4
Increased
54

ALPHABET INC-CL C

6.8M$817.5M2.1%$96.00+24.08%
19 qtrssince 2018-Q4
Decreased
0

ANTHEM INC

1.8M$802M2.1%$250.08+69.27%
19 qtrssince 2018-Q4
Increased
54

NEWMONT MINING CORP

18.5M$787.2M2.0%$30.51+29.25%
19 qtrssince 2018-Q4
Increased
54

UNIVERSAL HEALTH SERVICES-B

4.7M$739.3M1.9%$117.65+31.56%
19 qtrssince 2018-Q4
Decreased
0

BANK OF NEW YORK MELLON CORP

16.4M$731.7M1.9%$38.06+7.80%
19 qtrssince 2018-Q4
Decreased
0
$39.1B
AUM
388
Positions
Q2 2023
Filing
Rating · 3.0
Quarterly Portfolio Change
+2%Q1'22$40.8B-13%Q2'22$35.4B-6%Q3'22$33.3B+9%Q4'22$36.3B+4%Q1'23$37.8B+3%Q2'23$39.1B
Activity profile
$ moved · Q2'23
New2%Increased29%Decreased64%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.9 years
<1Q6%1-4Q14%1-2Y32%2Y+48%

First Eagle Investment Management, LLC manages $39.1B across 388 positions as of Q2 2023. Top holdings: ORCL (5.7%), META (4.2%), XOM (3.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3/5.0.

Q2 2023 Summary

Active quarter - 25 new positions, 30 exits, 218 increased. Top move: IMO (INCREASED, conviction 59). Portfolio: $39.1B across 388 positions.

Top holdings by portfolio weight

Total AUM$39B
ORCL5.71%
META4.20%
XOM3.66%
HCA3.54%
CMCSA3.45%
SLB3.43%
IMO3.15%
FMX3.11%
WTW2.99%
ABEV2.53%
Other2.34%

Portfolio allocation by GICS sector

Sectors11
Technology16.09%
Energy12.14%
Healthcare11.34%
Communication Services10.86%
Financial Services10.12%
Basic Materials9.84%
Consumer Defensive9.26%
Industrials7.11%
Real Estate5.67%
Unknown5.49%
Other2.09%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Energy, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Solid(3.0 / 5.0)
Track Record77
Conviction41
Concentration44
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BDXBDXBECTON DICKINSON AND CO
Q3 2024 Q2 2026+11M shares+$1.4B
8Q
BIOBIOBIO-RAD LABORATORIES-A
Q3 2024 Q2 2026+2M shares+$591.4M
8Q
BTIBTIBRITISH AMERICAN TOB-SP ADR
Q3 2024 Q2 2026+939,374 shares+$82M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used